New research presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people with ...

New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people ...

While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) ...

OLN324 targets both VEGF and Ang2, the same mechanism of action as Roche’s Vabysmo, the Swiss giant’s multi-blockbuster ...

Kalaris Therapeutics initiates a phase 1b/2 study for TH103, targeting neovascular age-related macular degeneration and ...

The use of anticoagulants or antiplatelets was linked to a higher risk of intraocular hemorrhage requiring vitrectomy in ...

IRON MOUNTAIN — Garrett Eye Center in Iron Mountain is offering a new non-invasive treatment for early stage dry macular ...

Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and efficacy in nAMD patients receiving four initial ...

The FDA has granted Fast Track Designation to Sanofi’s SAR402663, an investigational one-time intravitreal gene therapy for ...

Prior to this research study, only a single cross-sectional study was conducted to investigate the correlation between AMD ...

BrightFocus Foundation today launched two new national public service announcements, Stop AMD and Stop Glaucoma, to raise awareness of macular degeneration and glaucoma, leading causes of irreversible ...